COMMUNIQUÉS West-GlobeNewswire

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

05/09/2024 - 14:00

The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume [...]

Stockholders Vote to Elect Madhavan Balachandran to Board of Directors

05/09/2024 - 14:00

WOBURN, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced [...]

Olon poursuit sa croissance et annonce une nouvelle acquisition

05/09/2024 - 13:43

Olon, groupe chimico-pharmaceutique leader dans la production et le développement d’ingrédients pharmaceutiques actifs (API) et filiale de la holding P&R, poursuit sa croissance et annonce une nouvelle acquisition [...]

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting

05/09/2024 - 13:30

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of upcoming data presentations, highlighting data from both the ULTIMATE I & II Phase 3 trials and the [...]

Lexeo Therapeutics to Participate in Upcoming Investor Conferences

05/09/2024 - 13:30

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and [...]

Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05/09/2024 - 13:30

REDWOOD CITY, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on September 3, 2024, the Compensation Committee of Adverum’s Board of Directors granted [...]

Ocular Therapeutix™ to Present at September Retina Meetings

05/09/2024 - 13:30

BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a biopharmaceutical company committed to improving vision in the real world through the development and [...]

Bitech Technologies Signs Term Sheet of $80 Million Investment Tax Credit for Its Flagship BESS Project

05/09/2024 - 13:30

Advances 100MW Capacity Battery Energy Storage System Project Toward Commercialization in Q2 2025 Newport Beach, CA, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Bitech Technologies Corporation ( OTCQB: BTTC ), (the “Company” or [...]

First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of Congo

05/09/2024 - 13:19

Vaccine donations from the European Commission, the U.S. government and Bavarian Nordic are now entering the DRC, the epicenter of the mpox outbreak More than 250,000 doses to arrive over the next week, marking a [...]

BioNTech to Present Clinical Data Updates Across mRNA and Immunomodulatory Oncology Portfolio at ESMO Congress 2024

05/09/2024 - 13:15

MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the European Society for [...]

Major shareholder announcement

05/09/2024 - 13:07

Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]

Invivyd to Participate in Upcoming Investor Conferences

05/09/2024 - 13:01

WALTHAM, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will present [...]

Ocugen CSO to Participate in 5th Annual Gene Therapy for Ophthalmic Disorders Summit

05/09/2024 - 13:00

MALVERN, Pa., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and [...]

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

05/09/2024 - 13:00

BOSTON and SAN DIEGO, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule [...]

Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024

05/09/2024 - 13:00

CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the company [...]

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

05/09/2024 - 13:00

Eyenovia is planning for a U.S. launch for Clobetasol in late September 2024 NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company with two FDA-approved [...]

BioXcel Therapeutics Announces Initiation of SERENITY At-Home Pivotal Phase 3 Safety Trial of BXCL501 for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia

05/09/2024 - 13:00

E stimated 23 million annual agitation episodes in the at-home setting 1-3 No FDA-approved therapies in the at-home setting for acute treatment of agitation associated with bipolar disorders or schizophrenia NEW HAVEN, [...]

ProMIS Neurosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

05/09/2024 - 13:00

CAMBRIDGE, Massachusetts and TORONTO, Ontario, Sept. 05, 2024 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a biotechnology company focused on the generation and development of therapeutics targeting [...]

TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate

05/09/2024 - 13:00

Grant awarded by the National Cancer Institute (NCI) of the NIH to support clinical development of lead therapeutic candidate, TTX-MC138 BOSTON, Sept. 05, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: [...]